Singapore, May 28 -- Taiwan-based startup TFBS Bioscience, Inc. and Australia's QIMR Berghofer Medical Research Institute have jointly announced the signing of a Memorandum of Understanding (MoU), establishing a strategic partnership in the field of cell and gene therapy (CGT).

The collaboration aims to combine the expertise and resources of both organisations to advance the development of innovative therapies and expand international market opportunities.

In addition, both parties will enhance global market visibility and strengthen their presence in the Asia-Pacific region through joint participation in international industry events and resource integration. This cross-border collaboration is expected to bridge industry and research c...